Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Construction in Progress (2021 - 2022)

NovaBridge Biosciences (NBP) reported Construction in Progress of $874276.2 for Q4 2022, down 73.51% year-over-year from $3.3 million in Q4 2021, and down 73.51% on a QoQ basis from $3.3 million in Q4 2021.

NovaBridge Biosciences (NBP) has 2 years of Construction in Progress data on file, last reported at $874276.2 in Q4 2022.

  • Quarterly Construction in Progress fell 73.51% year-over-year to $874276.2 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $874276.2 (down 73.51% YoY) and the FY2022 annual result came in at $901000.0, down 72.7% from the prior year.
  • Construction in Progress fell to $874276.2 in Q4 2022 per NBP's latest filing, from $3.3 million in the prior quarter.
  • Across five years, Construction in Progress topped out at $3.3 million in Q4 2021 and bottomed at $874276.2 in Q4 2022.

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 874,276.16
Dec 31, 2021 3.30 Mn